The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification ...

Researchers compared ACS to USPSTF lung cancer screening criteria, assessing how ACS criteria affected overall eligibility as eligibility in racial/ethnic/gender subgroups.

Tool offers increased precision in estimating exacerbation risk Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. It is frequently seen in primary ...

Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads ...

Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

Chronic obstructive pulmonary disease (COPD) has become one of the world’s most lethal but least prioritised health crises.

In a new study, researchers found that being hospitalized for flu or COVID-19 was linked to a 24 percent increase in later ...

The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Barry Manilow has made a swift return to the music scene following surgery to remove a cancerous spot from his left lung. The ...

Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...

Researchers have found in a new study that the hemoglobin, albumin, lymphocyte, and platelet score serves as an independent predictor of 30-day readmission in patients with acute exacerbation ...